Compare Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roundhill S&P 500 0DTE Covered Call Strategy ETF vs Zoetis Inc — how do they compare? Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $39.49, while Zoetis Inc trades at $73.66 (market cap $31.14B). The key difference: Zoetis Inc pays a 2.81% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none, and Roundhill S&P 500 0DTE Covered Call Strategy ETF is trading nearer its 52-week high, Zoetis Inc nearer its low. Which is the better fit depends on your goals.
| XDTE | ZTS | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $44.76 | $156.76 |
52-Week Low | $36.00 | $71.91 |
Market Cap | — | $31.14B |
Enterprise Value | — | $38.70B |
Dividend Yield | — | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
XDTE (Roundhill S&P 500 0DTE Covered Call Strategy ETF) trades at $39.47 with no price change, showing technical bullish signals from moving averages while oscillators remain neutral. The fund generates weekly dividend payments through covered call strategies on S&P 500 options, though recent analysis questions the sustainability of its high yield claims. Support and resistance levels cluster around $39-40, indicating potential near-term consolidation.
The outlook remains cautious due to concerns about NAV erosion despite high dividend yields. Investment opportunity exists for income-focused investors seeking weekly distributions, but risks include potential return of capital and tax inefficiency. Recent media coverage highlights structural limitations compared to traditional S&P 500 funds, suggesting careful evaluation of the tradeoffs between income frequency and total returns.
Zoetis (ZTS) trades at $73.4, down 1.95% on the day, as technical indicators signal a bearish trend amid recent price weakness. Fundamentally, the company reported Q2 2026 EPS of $1.87, beating estimates, but revenue was flat and full-year guidance was cut due to softer pet healthcare demand. Analyst sentiment remains mixed with a consensus price target of $94.90, though recent news highlights competitive pressures and a securities class action lawsuit.
The stock presents a value opportunity given its attractive P/E of 12.29 and strong profitability margins, but near-term headwinds from U.S. companion-animal market challenges and legal overhangs pose risks. Upside depends on execution against revised 2026 targets and stabilization in core markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
